Literature DB >> 7273292

Autoradiography of "oval cells" appearing rapidly in the livers of rats fed N-2-fluorenylacetamide in a choline devoid diet.

S Sell, K Osborn, H L Leffert.   

Abstract

Autoradiographic analysis of liver sections from rats fed the hepatocarcinogen N-2-fluorenylacetamide (FAA) in a choline devoid (CD) diet suggests that proliferating small "oval" cells arise from a few small portally-situated cells, and spread rapidly across the entire liver lobule. Small cells with detectable grains are first located where liver plates meet the portal areas. This cell type gradually increases in number over a 10-12 day period, then proliferates rapidly. After 28 days, microscopic nodules consisting of heavily labeled large eosinophilic cells appear, whereas residual hepatocytes are not labeled. Combined immunofluorescent and autoradiographic labeling studies reveal that many of the small cells contain AFP; approximately half of the alpha-fetoprotein-containing cells are labeled with [3H]thymidine (dT). Feeding CD-FAA diets to rats with hepatocytes prelabeled with [3H]dT after 70% hepatectomy 7 weeks earlier provides data which suggest that small "oval" cells do not arise from prelabeled hepatocytes but, instead, infiltrate the prelabeled hepatocytes during the diet induced proliferative phase. We conclude that "oval" cells arise from a small number of portal cells, not from hepatocytes. Exact identification of the oval cell precursor is not possible, but it could be a "stem" cell. Although hepatocyte-like properties are found in small cells (e.g., albumin staining), there is no evidence that they differentiate into normally functioning hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7273292     DOI: 10.1093/carcin/2.1.7

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  21 in total

1.  Cellular origin of regenerating parenchyma in a mouse model of severe hepatic injury.

Authors:  K M Braun; E P Sandgren
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  The stem cells of the liver--a selective review.

Authors:  K Aterman
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Growth factor- and cytokine-driven pathways governing liver stemness and differentiation.

Authors:  Aránzazu Sánchez; Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

4.  Demonstration of glucose-6-phosphatase and peroxisomal catalase activity by ultrastructural cytochemistry in oval cells from livers of carcinogen-treated rats.

Authors:  F Plenat; L Braun; N Fausto
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

5.  Liver stem cells.

Authors:  Neil D Theise
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

6.  Connection of ductlike structures induced by a chemical hepatocarcinogen to portal bile ducts in the rat liver detected by injection of bile ducts with a pigmented barium gelatin medium.

Authors:  H A Dunsford; R Maset; J Salman; S Sell
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

7.  Triple Staining Including FOXA2 Identifies Stem Cell Lineages Undergoing Hepatic and Biliary Differentiation in Cirrhotic Human Liver.

Authors:  Charles E Rogler; Remon Bebawee; Joe Matarlo; Joseph Locker; Nicole Pattamanuch; Sanjeev Gupta; Leslie E Rogler
Journal:  J Histochem Cytochem       Date:  2016-11-24       Impact factor: 2.479

Review 8.  Evidence regarding a stem cell origin of hepatocellular carcinoma.

Authors:  Thomas Shupe; Bryon E Petersen
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

9.  Origin and fate of oval cells in dipin-induced hepatocarcinogenesis in the mouse.

Authors:  V M Factor; S A Radaeva; S S Thorgeirsson
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

Review 10.  Liver regeneration: alternative epithelial pathways.

Authors:  George K Michalopoulos
Journal:  Int J Biochem Cell Biol       Date:  2009-09-27       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.